These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9815773)

  • 1. Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer.
    Kubota Y; Miura T; Moriyama M; Noguchi S; Matsuzaki J; Takebayashi S; Hosaka M
    Clin Cancer Res; 1997 Jun; 3(6):973-6. PubMed ID: 9815773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer.
    Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):29-35. PubMed ID: 12497203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers.
    O'Brien TS; Fox SB; Dickinson AJ; Turley H; Westwood M; Moghaddam A; Gatter KC; Bicknell R; Harris AL
    Cancer Res; 1996 Oct; 56(20):4799-804. PubMed ID: 8841001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of thymidine phosphorylase in an in vitro model of human bladder cancer invasion.
    Jones A; Fujiyama C; Turner K; Cranston D; Williams K; Stratford I; Bicknell R; Harris AL
    J Urol; 2002 Mar; 167(3):1482-6. PubMed ID: 11832774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine phosphorylase activity in transitional cell cancer: relation to histological parameters and chemosensitivity to fluorouracil-related drugs.
    Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Anticancer Res; 2000; 20(6B):4315-8. PubMed ID: 11205264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different angiogenic pathways characterize superficial and invasive bladder cancer.
    O'Brien T; Cranston D; Fuggle S; Bicknell R; Harris AL
    Cancer Res; 1995 Feb; 55(3):510-3. PubMed ID: 7530595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
    Zhan J; Tang XD
    Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of thymidine phosphorylase in human superficial bladder cancer.
    Shimabukuro T; Matsuyama H; Baba Y; Jojima K; Suyama K; Aoki A; Suga A; Yamamoto N; Naito K
    Int J Urol; 2005 Jan; 12(1):29-34. PubMed ID: 15661051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue levels of pyrimidine nucleoside phosphorylase activity in human and rodent bladder cancer and normal bladder tissue.
    Fujimoto K; Matsumura Y; Tani Y; Ozono S; Hirao Y; Okajima E
    Int J Urol; 2007 Aug; 14(8):754-9. PubMed ID: 17681069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer.
    Aoki S; Yamada Y; Nakamura K; Taki T; Tobiume M; Honda N
    Oncol Rep; 2006 Aug; 16(2):279-84. PubMed ID: 16820903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma.
    Mizutani Y; Wada H; Fukushima M; Yoshida O; Nakanishi H; Li YN; Miki T
    Cancer; 2004 Feb; 100(4):723-31. PubMed ID: 14770427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of platelet-derived endothelial cell growth factor mRNA expression in superficial bladder cancer].
    Li G; Zhang YF; Ding Q; Yan CY; Wen DG
    Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(8):478-81. PubMed ID: 15144643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity is correlated with lower grade and lower stage bladder carcinomas.
    Okumura A; Mizuno I; Nagakawa O; Fuse H
    Int J Urol; 2004 Dec; 11(12):1082-6. PubMed ID: 15663679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Orotate phosphoribosyl transferase in bladder cancer].
    Furuse H; Hirano Y; Harada M; Mugiya S; Ushiyama T; Suzuki K; Ozono S
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1431-3. PubMed ID: 15446572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for the involvement of thymidine phosphorylase in cancer invasion.
    Gotanda T; Haraguchi M; Tachiwada T; Shinkura R; Koriyama C; Akiba S; Kawahara M; Nishiyama K; Sumizawa T; Furukawa T; Mimata H; Nomura Y; Akiyama S; Nakagawa M
    Int J Mol Med; 2006 Jun; 17(6):1085-91. PubMed ID: 16685420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
    Mazurek A; Kuc P; Terlikowski S; Laudanski T
    Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder.
    Arima J; Imazono Y; Takebayashi Y; Nishiyama K; Shirahama T; Akiba S; Furukawa T; Akiyama S; Ohi Y
    Cancer; 2000 Mar; 88(5):1131-8. PubMed ID: 10699904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in patients with interstitial cystitis and bladder carcinoma.
    Ueda T; Tamaki M; Ogawa O; Yoshimura N
    J Urol; 2002 Jan; 167(1):347-51. PubMed ID: 11743354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity in human bladder cancer.
    Lin Y; Miyamoto H; Fujinami K; Uemura H; Hosaka M; Iwasaki Y; Kubota Y
    Clin Cancer Res; 1996 Jun; 2(6):929-32. PubMed ID: 9816252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.